Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Iaina

Showing results (151-160 of 157) with videos related to

Pageof 16
Sort By:
You have reached the last page of results.This site can display upto 157 results.
Kidney International|August 1, 2000
Renal nitric oxide production during the early phase of experimental diabetes mellitusS Keynan, B Hirshberg, N Levin-Iaina, et al.
Journal of the American College of Cardiology|January 12, 2001
Interaction between paracrine tumor necrosis factor-alpha and paracrine angiotensin II during myocardial ischemiaI Frolkis, J Gurevitch, Y Yuhas, et al.
Journal of the American College of Cardiology|June 13, 2001
The effect of correction of mild anemia in severe, resistant congestive heart failure using subcutaneous erythropoietin and intravenous iron: a randomized controlled studyD S Silverberg, D Wexler, D Sheps, et al.
The Journal of Trauma|August 26, 1998
Methylene blue prevents pulmonary injury after intestinal ischemia-reperfusionY Galili, R Ben-Abraham, A Weinbroum, et al.
Clinical Nephrology|September 14, 2002
The correction of anemia in severe resistant heart failure with erythropoietin and intravenous iron prevents the progression of both the heart and the renal failure and markedly reduces hospitalizationD S Silverberg, D Wexler, M Blum, et al.
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|March 13, 2002
Aggressive therapy of congestive heart failure and associated chronic renal failure with medications and correction of anemia stops or slows the progression of both diseasesD S Silverberg, D Wexler, M Blum, et al.
Journal of the American College of Cardiology|June 7, 2000
The use of subcutaneous erythropoietin and intravenous iron for the treatment of the anemia of severe, resistant congestive heart failure improves cardiac and renal function and functional cardiac class, and markedly reduces hospitalizationsD S Silverberg, D Wexler, M Blum, et al.
Pageof 16

Showing results (151-160 of 157) with videos related to

Sort By:
Pageof 16
You have reached the last page of results.This site can display upto 157 results.
Kidney International|August 1, 2000
Renal nitric oxide production during the early phase of experimental diabetes mellitusS Keynan, B Hirshberg, N Levin-Iaina, et al.
Journal of the American College of Cardiology|January 12, 2001
Interaction between paracrine tumor necrosis factor-alpha and paracrine angiotensin II during myocardial ischemiaI Frolkis, J Gurevitch, Y Yuhas, et al.
Journal of the American College of Cardiology|June 13, 2001
The effect of correction of mild anemia in severe, resistant congestive heart failure using subcutaneous erythropoietin and intravenous iron: a randomized controlled studyD S Silverberg, D Wexler, D Sheps, et al.
The Journal of Trauma|August 26, 1998
Methylene blue prevents pulmonary injury after intestinal ischemia-reperfusionY Galili, R Ben-Abraham, A Weinbroum, et al.
Clinical Nephrology|September 14, 2002
The correction of anemia in severe resistant heart failure with erythropoietin and intravenous iron prevents the progression of both the heart and the renal failure and markedly reduces hospitalizationD S Silverberg, D Wexler, M Blum, et al.
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|March 13, 2002
Aggressive therapy of congestive heart failure and associated chronic renal failure with medications and correction of anemia stops or slows the progression of both diseasesD S Silverberg, D Wexler, M Blum, et al.
Journal of the American College of Cardiology|June 7, 2000
The use of subcutaneous erythropoietin and intravenous iron for the treatment of the anemia of severe, resistant congestive heart failure improves cardiac and renal function and functional cardiac class, and markedly reduces hospitalizationsD S Silverberg, D Wexler, M Blum, et al.
Pageof 16